Mucins in gastrointestinal cancers.

Michael S. Turner, John R. McKolanis, Ramesk K Ramanathan, David C. Whitcomb, Olivera J. Finn

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

The mucin family has been under study by molecular biologists, biochemists, pathologists and immunologists interested in cancer because of the role these molecules can play in the diagnosis and treatment of cancer. Immense knowledge has been accumulated, but the high speed of progress in the laboratory has not been matched by the progress towards applying this knowledge in the clinic. For example, specific knowledge of cancer-associated changes in the expression and glycosylation of various mucins, which can aid in the diagnosis as well as prognosis of GI cancers, has not yet led to the use of a panel of anti-mucin antibodies as a standard diagnostic tool. Similarly, many more opportunities exist for using mucin-based therapies than are currently being considered in the clinic. This chapter aimed to highlight some of these opportunities and to interest clinician scientists in exploring them in the near future.

Original languageEnglish (US)
Pages (from-to)259-274
Number of pages16
JournalCancer chemotherapy and biological response modifiers
Volume21
StatePublished - 2003
Externally publishedYes

Fingerprint

Gastrointestinal Neoplasms
Mucins
Neoplasms
Glycosylation
Anti-Idiotypic Antibodies
Therapeutics

Cite this

Turner, M. S., McKolanis, J. R., Ramanathan, R. K., Whitcomb, D. C., & Finn, O. J. (2003). Mucins in gastrointestinal cancers. Cancer chemotherapy and biological response modifiers, 21, 259-274.

Mucins in gastrointestinal cancers. / Turner, Michael S.; McKolanis, John R.; Ramanathan, Ramesk K; Whitcomb, David C.; Finn, Olivera J.

In: Cancer chemotherapy and biological response modifiers, Vol. 21, 2003, p. 259-274.

Research output: Contribution to journalReview article

Turner, MS, McKolanis, JR, Ramanathan, RK, Whitcomb, DC & Finn, OJ 2003, 'Mucins in gastrointestinal cancers.', Cancer chemotherapy and biological response modifiers, vol. 21, pp. 259-274.
Turner, Michael S. ; McKolanis, John R. ; Ramanathan, Ramesk K ; Whitcomb, David C. ; Finn, Olivera J. / Mucins in gastrointestinal cancers. In: Cancer chemotherapy and biological response modifiers. 2003 ; Vol. 21. pp. 259-274.
@article{55ec38a3b9414837a9132e16046d791f,
title = "Mucins in gastrointestinal cancers.",
abstract = "The mucin family has been under study by molecular biologists, biochemists, pathologists and immunologists interested in cancer because of the role these molecules can play in the diagnosis and treatment of cancer. Immense knowledge has been accumulated, but the high speed of progress in the laboratory has not been matched by the progress towards applying this knowledge in the clinic. For example, specific knowledge of cancer-associated changes in the expression and glycosylation of various mucins, which can aid in the diagnosis as well as prognosis of GI cancers, has not yet led to the use of a panel of anti-mucin antibodies as a standard diagnostic tool. Similarly, many more opportunities exist for using mucin-based therapies than are currently being considered in the clinic. This chapter aimed to highlight some of these opportunities and to interest clinician scientists in exploring them in the near future.",
author = "Turner, {Michael S.} and McKolanis, {John R.} and Ramanathan, {Ramesk K} and Whitcomb, {David C.} and Finn, {Olivera J.}",
year = "2003",
language = "English (US)",
volume = "21",
pages = "259--274",
journal = "Cancer chemotherapy and biological response modifiers",
issn = "0921-4410",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Mucins in gastrointestinal cancers.

AU - Turner, Michael S.

AU - McKolanis, John R.

AU - Ramanathan, Ramesk K

AU - Whitcomb, David C.

AU - Finn, Olivera J.

PY - 2003

Y1 - 2003

N2 - The mucin family has been under study by molecular biologists, biochemists, pathologists and immunologists interested in cancer because of the role these molecules can play in the diagnosis and treatment of cancer. Immense knowledge has been accumulated, but the high speed of progress in the laboratory has not been matched by the progress towards applying this knowledge in the clinic. For example, specific knowledge of cancer-associated changes in the expression and glycosylation of various mucins, which can aid in the diagnosis as well as prognosis of GI cancers, has not yet led to the use of a panel of anti-mucin antibodies as a standard diagnostic tool. Similarly, many more opportunities exist for using mucin-based therapies than are currently being considered in the clinic. This chapter aimed to highlight some of these opportunities and to interest clinician scientists in exploring them in the near future.

AB - The mucin family has been under study by molecular biologists, biochemists, pathologists and immunologists interested in cancer because of the role these molecules can play in the diagnosis and treatment of cancer. Immense knowledge has been accumulated, but the high speed of progress in the laboratory has not been matched by the progress towards applying this knowledge in the clinic. For example, specific knowledge of cancer-associated changes in the expression and glycosylation of various mucins, which can aid in the diagnosis as well as prognosis of GI cancers, has not yet led to the use of a panel of anti-mucin antibodies as a standard diagnostic tool. Similarly, many more opportunities exist for using mucin-based therapies than are currently being considered in the clinic. This chapter aimed to highlight some of these opportunities and to interest clinician scientists in exploring them in the near future.

UR - http://www.scopus.com/inward/record.url?scp=4444350365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444350365&partnerID=8YFLogxK

M3 - Review article

C2 - 15338749

AN - SCOPUS:4444350365

VL - 21

SP - 259

EP - 274

JO - Cancer chemotherapy and biological response modifiers

JF - Cancer chemotherapy and biological response modifiers

SN - 0921-4410

ER -